Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma

Abstract

This study demonstrates that the GPS, an inflammation-based prognostic score, is an independent marker of poor prognosis in patients with HCC and is superior to the other inflammation-based prognostic scores in terms of prognostic ability.